The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom.
Researchers at King's College London, using data from the ZOE COVID Symptom study app, found the odds of developing long COVID after infection were 20% to 50% lower during the Omicron wave in the UK compared to Delta. The figure varied depending on the patient's age and the timing of their last vaccination.
The study from King's is believed to be the first academic research to show Omicron does not present as great a risk of long COVID, but that does not mean long COVID patient numbers are dropping, the team said. "It's good news, but please don't decommission any of your long COVID services," lead researcher Dr Claire Steves told Reuters, appealing to health-service providers.
It also said the risk of lingering symptoms after Omicron was lower than with Delta, but only for double-vaccinated people. It found no statistical difference for those who were triple vaccinated.